Company News
Company News
Core One Labs Unaware of Any Material Change that Would Account for Significant Share Price Depreciation
May 04, 2021
Vancouver, British Columbia, Canada – May 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
Core One Labs Completes Milestone Acquisition of Akome Biotech
May 04, 2021
Vancouver, British Columbia, Canada – May 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research...
Read more
Company News
Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech
April 29, 2021
Vancouver, British Columbia, Canada – April 29, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”), a biotechnology research...
Read more
Company News
CORE ONE LABS ANNOUNCES DELAY OF FILINGS
April 28, 2021
Vancouver, British Columbia, Canada – April 28, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”)...
Read more
Company News
Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin
April 28, 2021
Vancouver, British Columbia, Canada – April 28, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
April 24, 2021
Vancouver, British Columbia, Canada – April 24, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more